Christopher Flint OBrien, Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 6,925 shares at $61.04 ($423K) on 2017-10-02, disclosed to the SEC on 2017-10-03.
Open-market sale of $423k NBIX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NBIX | SELL | 2017-11-06 | $7.4M | — | Filing → |
| NBIX | SELL | 2017-09-07 | $6.1M | — | Filing → |
| NBIX | SELL | 2017-07-31 | $437K | — | Filing → |